Literature DB >> 18984969

Postoperative adjuvant radiation therapy in the treatment of primary head and neck mucosal melanomas.

Juliano P Nakashima1, Célia M Viégas, Ana L Fassizoli, Marcelo Rodrigues, Leonardo A G Chamon, João H C Silva, Fernando L Dias, Carlos M Araújo.   

Abstract

BACKGROUND/AIMS: The role of postoperative radiotherapy (PORT) in head and neck mucosal melanomas (HNMM) is not yet clearly defined. The aim of this study is to report the 21-year experience of the Brazilian National Cancer Institute in such treatment.
METHODS: From January 1983 to December 2003, 31 patients with confirmed histological diagnosis of HNMM underwent treatment at the Brazilian National Cancer Institute. Of these, 20 received radical treatment with surgery alone (8 patients--group 1) or surgery and PORT (12 patients--group 2).
RESULTS: Local control and the median time to local failure at 5 years were 75% and 14 months for group 1 and 83.5% and 40 months for group 2 (p = 0.06). The overall survival rates at 3 years were 37.5% for group 1 and 58% for group 2. At 5 years the survival rates were 25% for both groups (p = NS). When PORT was initiated within 60 days after surgery, there was a trend towards improvement in overall survival (p = 0.08). After univariate analysis, distant metastasis, location of primary disease and tobacco smoking were important prognostic factors.
CONCLUSION: Early (<60 days) PORT for HNMM provides better local control with a longer disease-free survival. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2008        PMID: 18984969     DOI: 10.1159/000163029

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  4 in total

1.  Spindle cell amelanotic lesion of the tongue: a diagnostic and therapeutic challenge.

Authors:  Vinay Kumar; Mridula Shukla; Umakanth Goud; Devendra Kumar Ravi; Mohan Kumar; Manoj Pandey
Journal:  Indian J Surg       Date:  2012-09-07       Impact factor: 0.656

2.  Neck dissection and post-operative chemotherapy with dimethyl triazeno imidazole carboxamide and cisplatin protocol are useful for oral mucosal melanoma.

Authors:  Xi Yang; Guo-Xin Ren; Chen-Ping Zhang; Guo-Yu Zhou; Yong-Jie Hu; Wen-Jun Yang; Wei Guo; Jiang Li; Lai-Ping Zhong
Journal:  BMC Cancer       Date:  2010-11-11       Impact factor: 4.430

3.  [Malignant melanoma: a rare tumor of the nasal cavity--about a series of 10 cases].

Authors:  Amal Errachdi; Brice Nkoua Epala; Amal Asabbane; Naoual Kabbali; Mariem Hemmich; Tayeb Kebdani; Noureddine Benjaafar
Journal:  Pan Afr Med J       Date:  2014-05-28

4.  Sinonasal Melanoma: A Case Report and Literature Review.

Authors:  I S S Alves; L G S Berriel; R T Alves; M B Pinto; C F P Oliveira; A C Cazzotto; W V Moura
Journal:  Case Rep Oncol Med       Date:  2017-01-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.